Haemonetics Funding: How Much Did They Raise & Key Investors

How Much Did Haemonetics Raise?
Funding & Key Investors

Haemonetics, a global healthcare company, has recently secured a major strategic investment, contributing to its total funding of $730M. This recent capital infusion of $730M underscores the company's ongoing efforts to enhance patient care and reduce healthcare costs through its innovative medical products and solutions.

What is Haemonetics?

Haemonetics

Manufacturing

Medical Devices & Equipment

Haemonetics operates within critical segments of the healthcare market, focusing on blood and plasma component collection, the surgical suite, and hospital transfusion services. The company's technological advancements are designed to improve outcomes for patients and optimize operational efficiencies for healthcare providers. With a legacy built on dynamic product development and a culture of innovation, Haemonetics remains committed to quality and integrity in its pursuit of making a significant impact on global health.

How much funding has Haemonetics raised?

Haemonetics has raised a total of $730M across 1 funding round:

2022

Debt

$730M

Debt (2022): $730M, investors not publicly disclosed

What's next for Haemonetics?

The recent major strategic investment signals a pivotal phase for Haemonetics, likely enabling accelerated expansion of its product lines and market reach. This influx of capital is expected to fuel further research and development into its core areas, potentially leading to new solutions for blood management and surgical procedures. The company's focus on improving patient care and cost-effectiveness positions it for continued growth and influence within the enterprise-level healthcare sector.

See full Haemonetics company page

See More Financial Insights